|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.
The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Raymond James on May 25, 2021. The analyst firm set a price target for 12.00 expecting VKTX to rise to within 12 months (a possible 95.44% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $6.14 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Viking Therapeutics.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.